BYOMass Company
BYOMass is developing therapeutics to modulate the central control of metabolism associated with aging and age-related chronic illnesses.
Headquarters:
Sudbury, Massachusetts, United States
Total Funding:
1500000
Founded Date:
2017
Investors Number:
1
Last Funding Date:
2019
Investor Type:
Company
Number Of Exists:
Venture - Series Unknown
Technology:
Geroscience
Employee Number:
1-10
Industry:
Biotechnology
Last Funding Type:
Venture - Series Unknown